Atara Biotherapeutics, Inc. (ATRA)
9.76
+0.23
(+2.41%)
USD |
NASDAQ |
Sep 04, 16:00
10.34
+0.58
(+5.94%)
After-Hours: 20:00
Atara Biotherapeutics Price : 9.76 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 9.45 | 9.95 | 9.25 | 9.76 | 135656.0 |
| Sep 03, 2026 | 9.49 | 9.53 | 9.00 | 9.53 | 25276.00 |
| Sep 02, 2026 | 9.08 | 9.48 | 9.08 | 9.44 | 20899.00 |
| Sep 01, 2026 | 8.96 | 9.18 | 8.80 | 9.02 | 51945.00 |
| Aug 31, 2026 | 9.09 | 9.29 | 8.83 | 8.90 | 30242.00 |
| Aug 28, 2026 | 9.18 | 9.21 | 8.90 | 9.20 | 15346.00 |
| Aug 27, 2026 | 9.38 | 9.60 | 9.165 | 9.25 | 26950.00 |
| Aug 26, 2026 | 9.65 | 9.84 | 9.38 | 9.38 | 63750.00 |
| Aug 25, 2026 | 9.57 | 10.02 | 9.538 | 9.84 | 48514.00 |
| Aug 24, 2026 | 9.57 | 9.66 | 9.31 | 9.46 | 23967.00 |
| Aug 21, 2026 | 9.46 | 9.89 | 9.15 | 9.70 | 27086.00 |
| Aug 20, 2026 | 9.60 | 9.74 | 9.14 | 9.38 | 28020.00 |
| Aug 19, 2026 | 8.85 | 9.74 | 8.276 | 9.60 | 79152.00 |
| Aug 18, 2026 | 8.34 | 8.90 | 8.34 | 8.72 | 29501.00 |
| Aug 17, 2026 | 8.00 | 8.48 | 7.81 | 8.36 | 66103.00 |
| Aug 14, 2026 | 8.51 | 8.51 | 7.99 | 8.09 | 66248.00 |
| Aug 13, 2026 | 8.34 | 9.24 | 7.73 | 8.51 | 126517.0 |
| Aug 12, 2026 | 8.88 | 9.43 | 8.70 | 9.225 | 90000.00 |
| Aug 11, 2026 | 8.62 | 9.04 | 8.359 | 8.94 | 29246.00 |
| Aug 10, 2026 | 8.42 | 8.80 | 8.09 | 8.61 | 45333.00 |
| Aug 07, 2026 | 8.30 | 8.485 | 8.202 | 8.45 | 23214.00 |
| Aug 06, 2026 | 8.60 | 8.645 | 8.090 | 8.25 | 22856.00 |
| Aug 05, 2026 | 8.60 | 8.98 | 8.380 | 8.54 | 32524.00 |
| Aug 04, 2026 | 8.55 | 9.11 | 8.55 | 8.77 | 42283.00 |
| Aug 03, 2026 | 8.42 | 8.660 | 8.255 | 8.55 | 53236.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.19 |
Price Related Metrics
| PS Ratio | 19.70 |
| PEG Ratio | -0.0305 |
| Earnings Yield | -14.33% |
| Market Cap | 92.16M |
| PEGY Ratio | -0.0305 |